[Vaccinations in patients with autoimmune diseases].
The number of individuals with autoimmune diseases treated with immunosuppressive drugs is increasing steadily. The variety of immunosuppressive drugs and in particular biological therapies is also rising. The autoimmune disease itself as well as the immunosuppressive therapy increases the risk of infection in this population. Particularly the risk of vaccine-preventable infections is elevated. Thus, preventing infections by the means of vaccination is of utmost importance. The Division of Infectious Diseases of the Epidemiology, Biostatistics and Prevention Institute, University of Zurich, performed a literature search on the topic of vaccinations in patients with autoimmune diseases upon request by the Swiss Federal Commission for Vaccination Issues. Overall, data are scarce. The following main points were retrieved from the literature: Inactivated vaccines are safe, but their immunogenicity may be reduced under immunosuppressive therapy. In addition to the generally recommended basic vaccinations, specific vaccinations, such as influenza and pneumococcal vaccination are indicated in these patient groups. Live vaccines are generally contraindicated under immunosuppressive therapy due to safety concerns. However, specific exceptions apply. Furthermore, certain time intervals for the administration of live vaccines after pausing or ceasing an immunosuppressive therapy should be respected.
1 Departement Public Health, Abteilung Übertragbare Krankheiten, Institut für Epidemiologie, Biostatistik und Prävention, Universität Zürich.
Silja
S
Bühler
1 Departement Public Health, Abteilung Übertragbare Krankheiten, Institut für Epidemiologie, Biostatistik und Prävention, Universität Zürich.|2 Departement Medizin und Diagnostik (MEDDIA), Schweizerisches Tropen- und Public Health-Institut, Basel.
Christoph
C
Hatz
D001327:Autoimmune Diseases / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007110:Immunity, Active / Q000187:drug effects / Q000276:immunology; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D009894:Opportunistic Infections / Q000276:immunology* / Q000517:prevention & control*; D014612:Vaccines / Q000008:administration & dosage* / Q000276:immunology*
D007166:Immunosuppressive Agents; D014612:Vaccines